Sources and References

• Monteiro-Riviere and Tran, Nanotoxicology: Progress toward Nanomedicine, 2nd ed., CRC Press.
• Poole and Owens, Introduction to Nanotechnology, Wiley.
• NIOSH, Current Intelligence Bulletin 65: Occupational Exposure to Carbon Nanotubes and Nanofibers.
• OECD, Guidance on Sample Preparation and Dosimetry for the Safety Testing of Manufactured Nanomaterials.
• Canadian Council of Professional Engineers, Guideline on the Code of Ethics.

Chapter 1: Nanomaterials as a Hazard Category

Nanoscale materials have properties that differ from their bulk counterparts in ways that matter for human health: smaller size, larger specific surface area, tunable surface chemistry, and in some cases novel reactivity. Understanding the health risk of a nanomaterial is not a matter of extending bulk toxicology; it demands a framework built around the specific physics and chemistry that make nanotechnology valuable in the first place.

1.1 Why Size and Shape Matter

A nanoparticle’s specific surface area scales inversely with diameter. Reactive sites per gram — catalytic sites, reactive oxygen species generators, binding sites — increase by orders of magnitude as size drops. A 1 gram dose of 1 μm particles presents a different biological target than 1 gram of 10 nm particles.

Shape, aspect ratio, and rigidity matter too. High-aspect-ratio fibres (carbon nanotubes, asbestos) can trigger frustrated phagocytosis: immune cells attempt to engulf fibres longer than the cell itself, fail, and release inflammatory mediators. The parallel with asbestos, a documented carcinogen at similar shapes, has motivated intensive investigation of long, rigid nanotubes.

1.2 Surface Chemistry

Surface ligands, oxidation state, and solubility modulate toxicity. Silver nanoparticles release Ag⁺ ions in biological fluids; the toxic species is often the ion rather than the particle. Functional coatings (PEG, silica) alter biodistribution and may reduce or modify toxicity. Two batches of “silver nanoparticles” of nominally the same size can behave very differently if their surface chemistries differ.

Chapter 2: Exposure Routes and Biological Fate

2.1 Inhalation

Airborne nanoparticles deposit along the respiratory tract at size-dependent rates. Deposition in the alveolar region peaks near 20 nm; agglomerates deposit higher in the airway by inertial impaction. Clearance by mucociliary escalator and alveolar macrophages removes much of the deposited dose, but particles may translocate across the alveolar epithelium into blood and lymph, reaching liver, spleen, kidneys, and — rarely — brain.

The multiple-path particle dosimetry (MPPD) model computes deposition fractions by generation of the airway tree; exposure assessment uses measured particle concentrations and size distributions together with MPPD to estimate lung burden per work shift.

2.2 Dermal and Ingestion Routes

The intact skin barrier is generally effective against nanoparticles, though abraded skin and follicles provide access. Ingestion is an accidental route for workers who eat or drink in contaminated environments, and intentional for consumers of products containing nanomaterials (food additives, coatings on packaging). Gastrointestinal uptake is size- and coating-dependent and often modest but not zero.

2.3 Biodistribution

Once in the circulation, nanoparticles distribute according to size, shape, charge, and protein corona. The reticuloendothelial system (liver, spleen) accumulates many types. Long-circulating particles designed for drug delivery avoid RES uptake through steric coatings and size tuning. Excretion is renal for particles below about 6 nm hydrodynamic diameter and hepatobiliary for larger ones.

Chapter 3: Mechanisms of Toxicity

3.1 Oxidative Stress

Many nanomaterials catalyze the formation of reactive oxygen species at their surfaces. Cellular oxidative stress damages lipids, proteins, and DNA, and activates inflammation pathways. Antioxidant defences (glutathione, superoxide dismutase, catalase) counter ROS but can be overwhelmed by sustained or high-dose exposure.

3.2 Inflammation

Recognition of nanoparticles by macrophages triggers cytokine release. Persistent exposure maintains chronic inflammation, a recognized driver of carcinogenesis and fibrotic disease. Granuloma formation around indigestible particles is a hallmark of long-term fibre exposure.

3.3 Cytotoxicity, Mutagenicity, and Carcinogenicity

Acute cytotoxicity is measured in vitro with assays such as MTT, LDH release, and live–dead imaging. Genotoxicity is assessed by comet assay, micronucleus, and Ames tests. Carcinogenicity requires long-term in vivo studies and mechanistic weight-of-evidence. For carbon nanotubes of specific dimensions and rigidity, mesothelioma induction in rodents has parallels with asbestos and motivates precautionary handling.

Chapter 4: Exposure Assessment and Risk Management

4.1 Measurement Methods

Occupational exposure to nanomaterials is assessed with real-time number-counting instruments (condensation particle counters, scanning mobility particle sizers), mass-based samplers (respirable cyclones with filter analysis), and surface-area analyzers (nanoparticle surface area monitors). Task-based sampling contrasts concentrations during specific operations with background levels to attribute exposure to process activities.

4.2 Control Hierarchy

Industrial-hygiene practice applies a hierarchy: eliminate, substitute, engineer, administer, and protect. Elimination and substitution — using less hazardous or bulk alternatives — are preferred. Engineering controls include containment, enclosed-process design, local exhaust ventilation with HEPA filtration, and wet handling. Administrative controls include work-shift limits, training, and hygiene practices. Personal protective equipment — respirators, gloves, coveralls — is the final layer, and is specified by exposure level and task.

4.3 Regulatory Context

Occupational exposure limits for nanomaterials remain under development. NIOSH has issued recommended exposure limits for titanium dioxide (0.3 mg/m³) and carbon nanotubes (1 μg/m³ elemental carbon). Jurisdictions differ in classification: REACH in the EU and Canadian CEPA in Canada impose substance-specific data requirements. Products for medical or food use carry additional regulatory pathways.

4.4 Cancer and Non-Cancer Risks

Risk assessment quantifies cancer risk as excess lifetime cancer incidence associated with a given exposure level and non-cancer risk through hazard quotients comparing exposure to a reference dose. For nanomaterials the data are often sparse and the uncertainty factors large, driving conservative occupational and environmental standards.

Chapter 5: Nanotechnology Engineering Practice

5.1 Fields of Practice

Nanotechnology engineers work across semiconductors and microelectronics, medical devices and pharmaceuticals, energy storage and conversion, materials and coatings, environmental and water technologies, and research. Each field brings particular process, characterization, and regulatory skill demands, but they share a common engineering approach: define the specification, design and fabricate to meet it, characterize rigorously, manage hazards at every step.

5.2 Connections with Other Engineering Plans

Nanotechnology does not exist in isolation. Mechatronics, materials, chemical, electrical, and biomedical engineers all contribute to nanotechnology projects. Project success depends on clear communication across these boundaries: a materials engineer providing a nanostructured coating must document particle size, composition, and surface chemistry for the mechatronics engineer who integrates it into a sensor; the nanotechnology engineer bridging them must speak both vocabularies.

5.3 Early Professional Practice

Early engineering practice in nanotechnology often involves sample preparation, characterization, literature review, and disciplined laboratory documentation under supervision. The skills developed — laboratory safety, instrument discipline, clear reporting, and project documentation — are the foundation for more autonomous technical work later.

5.4 Professional Formation

Engineering practice is governed by a statutory profession with codes of ethics and legal responsibilities. Engineering in Ontario is regulated by Professional Engineers Ontario; equivalent bodies regulate practice in every Canadian province. Professional formation includes the code of ethics, duties to public safety, conflicts of interest, and the limits of professional responsibility. Engineers document their learning and experience carefully because that record later supports licensure and accountability.

5.5 Communication

Engineers are judged as much by their ability to explain as by their ability to design. Writing clear reports, giving focused presentations, drawing annotated schematics, and reading critically the work of others are skills as essential as circuit analysis or chemical intuition.